Introduction
The Institute for Health Metrics and Evaluation (IHME) faces a critical trade-off: expanding the Global Burden of Disease Study to cover more countries or increasing the depth of data for existing countries. This decision will significantly impact global health research and policy-making. I'll analyze this trade-off by examining the product context, stakeholders, metrics, and potential outcomes to provide a strategic recommendation.
I'll use a structured framework to evaluate this trade-off, considering both short-term impacts and long-term strategic implications for IHME and global health research.
Step 1
Clarifying Questions (3 minutes)
Why it matters: Helps understand the baseline and potential for improvement Expected answer: Covers 195 countries with varying depth Impact on approach: Would inform the potential scale of expansion vs. deepening
Why it matters: Helps prioritize solution against strategic objectives Expected answer: Balanced approach needed to satisfy both research goals and funding requirements Impact on approach: Would influence the balance between expansion and depth
Why it matters: Ensures the solution addresses key stakeholder requirements Expected answer: Researchers, policymakers, and healthcare professionals with varying data needs Impact on approach: Would guide the decision between breadth and depth based on user priorities
Why it matters: Assesses the practical implications of each option Expected answer: Expansion faces more logistical challenges, while deepening requires more intensive methods Impact on approach: Would influence resource allocation and timeline considerations
Why it matters: Determines the feasibility of different approaches Expected answer: Limited resources with potential for targeted expansion Impact on approach: Would help prioritize between expansion and depth based on available resources
Practice similar questions
Subscribe to access the full answer